Joined Today: 14

ALTU Altus Pharmaceuticals, Stock Message Board

All Messages

ALTU Message Board Home | Join The ALTU Group |

#19: Altus Pharmaceuticals Announces Achievement of Primary Endpoint in Phase 3 Efficacy Trial of Trizytek for Cystic Fibrosis Patients with Pancreatic Insufficiency
TheMachine	August 20, 2008 01:11:22 AM
Investor Conference Call Scheduled for 4:30 PM ET on August 11, 2008 Detailed Results to be Presented at North American Cystic Fibrosis Conference in October 2008 ... view message ignore post recommend post

#18: Altus Pharmaceuticals Announces Webcast of Presentation at Collins Stewart Growth Conference
TheMachine	July 9, 2008 12:10:35 PM
Altus Pharmaceuticals Inc. (NASDAQ: ALTU), announced today that Georges Gemayel, Ph.D., President and CEO of Altus, will present at the Collins Stewart Fourth Annual... view message ignore post recommend post

#17: Altus Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference
NewsBot	April 13, 2008 03:50:05 PM
Altus Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference Altus Pharmaceuticals Inc. (NASDAQ: ALTU) today announced that Jonathan Lieber, Chief... view message ignore post recommend post

#16: ALTU News Altus Pharmaceuticals Reports Fourth Quarter and Year End 2006 Financial Results and Provides Milestones for 2007
NewsBot	March 12, 2007 04:47:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for gastrointestinal and... view message ignore post recommend post

#15: ALTU News Altus Pharmaceuticals to Webcast Presentation at the Cowen and Company 27th Annual Health Care Conference
NewsBot	March 9, 2007 06:36:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU) today announced that management will present a company overview at the Cowen and Company 27th Annual Health... view message ignore post recommend post

#14: ALTU News Altus Pharmaceuticals to Host Fourth Quarter and Year End Investor Conference Call on March 12, 2007
NewsBot	March 6, 2007 12:09:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--On Monday, March 12, 2007 before the market opens, Altus Pharmaceuticals Inc. (NASDAQ: ALTU) expects to release to the news wire its results for the... view message ignore post recommend post

#13: ALTU News Altus Pharmaceuticals Enters into Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Products for Growth Hormone Deficient Patients
NewsBot	December 20, 2006 05:14:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that it has entered into an agreement with Genentech, Inc. to develop, manufacture and... view message ignore post recommend post

#12: ALTU News Altus Pharmaceuticals Appoints Bruce A. Leicher General Counsel
NewsBot	December 19, 2006 05:13:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#11: ALTU News Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
NewsBot	November 21, 2006 05:30:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#10: ALTU News Altus Pharmaceuticals Reports Positive ALTU-237 Pre-Clinical Data for Reducing Hyperoxaluria, a Precusor to Kidney Stone Formation
NewsBot	November 20, 2006 05:30:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#9: ALTU News Altus Pharmaceuticals Secures ALTU-135 Commercial Manufacturer
NewsBot	November 17, 2006 06:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#8: ALTU News Altus Pharmaceuticals Plans to Initiate ALTU-135 Phase III Trial in the Second Quarter of 2007
NewsBot	November 15, 2006 04:03:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#7: ALTU News Altus Pharmaceuticals Reports Third Quarter Financial Results
NewsBot	November 15, 2006 04:01:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for gastrointestinal and... view message ignore post recommend post

#6: ALTU News Altus Pharmaceuticals Announces Presentation of ALTU-238 Phase II Data at International Congress of Growth Hormone and Insulin-Like Growth Factor Research Societies
NewsBot	November 13, 2006 05:32:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with ... view message ignore post recommend post

#5: ALTU News Altus Pharmaceuticals Secures Phase III Manufacturer, Althea Technologies, for ALTU-238
NewsBot	August 21, 2006 01:10:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 21, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on the development and commercialization of oral and injectable... view message ignore post recommend post

Group Home | Login if you want to post a message